Cilian’s unique and novel CIBEX expression platform for biopharmaceuticals will be displayed on a banner at Phyton Biotech’s booth #121A50 at CPhI International 2022 in Frankfurt/Main, Germany from November 1-3. Phyton is Cilian’s preferred manufacturing partner for the therapeutic products developed and manufactured using CIBEX. CIBEX utilizes the unique qualities and capabilities of Ciliates in the production of fully recombinant therapeutic digestive enzymes (Lipase) and fully recombinant antigens for a quadrivalent seasonal influenza vaccine. Phyton has established Cilian’s CIBEX platform at its facility in Ahrensburg, Germany and is already manufacturing Cilian’s therapeutic digestive enzyme at 6,000 liter scale. Should you be interested to learn more about CIBEX, please visit the Phyton stand #121A50 at CPhI or www.cilian.de.